SEK 16.8 million from the Swedish Heart Lung Foundation to MedH researchers

Eleven researchers at the Department of Medicine, Huddinge (MedH), have been awarded grants from the Swedish Heart Lung Foundation. Together, they have been awarded SEK 16 808 000 for funding periods spanning 2026-2029.

Frieder Braunschweig , ICCA

Awarded for 2027-2029: SEK 1 800 000

Project title: Symtomatiska idiopatiska ventrikulära extraslag (VES): naturalförlopp, betydelsen av symtomupptagenhet och effekt av internet-KBT

Jonas Brinck , CeRM

Awarded for 2027-2028: SEK 1 000 000

Project title: Livstidsexponering av kolesterol, tidigt insatt förebyggande behandling och hälsoekonomiska vinster för att förhindra hjärtkärlsjukdom

Emmanouil Charitakis , ICCA

Awarded for 2027: SEK 800 000

Project title: Assessment of the effect of catheter ablation on elderly population with atrial fibrillation; a randomized controlled study; The ACE-AF study

Maria Eriksson , ICCA

Awarded for 2027-2029: SEK 2 400 000

Project title: Somatiska mutationer i kärlväggen och deras funktion i samband med ateroskleros

Rongrong Fan , GUT

Awarded for 2027-2029: SEK 1 500 000

Project title: Uncovering female-specific drivers of cardiovascular inflammation beyond hormones

Jennifer Härdfeldt , CeRM

Awarded for 2027-2028: SEK 608 000

Project title: Mechanisms of residual cardiovascular risk despite LDL cholesterol lowering

Paolo Parini , CeRM

Awarded for 2027-2029: SEK 1 500 000

Project title: Remnant – SCAPIS Stockholm – Sex-specific lipoprotein function and multimodal prediction of coronary stenosis and atherosclerosis progression

Stefano Romeo , CeRM

Awarded for 2027-2029: SEK 2 400 000

Project title: RE-DEFINING STEATOTIC LIVER DISEASE BY ELUCIDATING THE PATHOPHYSIOLOGY OF SYSTEMIC MASLD AND ITS ROLE IN HEART FAILURE

Johan Sandberg , CIM

Awarded for 2027-2029: SEK 2 100 000

Project title: Immunological mechanisms as mediators of immune defense and markers of pathology and treatment effects in cystic fibrosis

Karolina Szummer , ICCA

Awarded for 2027-2028: SEK 1 620 000

Project title: Atrial fibrillation and recurrence after cardioversion – can treatment with dapagliflozin reduce the rate of recurrence? (The RECUR-AF study)

Georgios Vavilis , CeRM

Awarded for 2026-2027: SEK 1 080 000

Project title: Elucidating the Liver-Heart Axis in MASLD and Cardiometabolic HFpEF

/Public Release. View in full here.